KATE CATUDAL: Open Payments
NPI 1780340554 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 24 payments from 9 companies in 2025. Trend: 2023 $429 · 2024 $277 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $110 |
| PFIZER INC. | 4 | $85 |
| Lilly USA, LLC | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $45 |
| HARMONY BIOSCIENCES LLC | 1 | $41 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: KISUNLA, JARDIANCE, WAKIX, UBRELVY, PAXLOVID, BREZTRI, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across RI — which companies pay providers there.
